ELISA-Based Tests is Expected to dominate the Growth of the Global Dengue Diagnostics and Treatment Market

The global dengue diagnostics & treatment market is anticipated to grow at a considerable CAGR of 5.5% during the forecast period (2021-2027). One of the most prevalent and commonly acknowledged procedures for detecting dengue fever is the enzyme-linked immunosorbent assay (ELISA). The test detects anti-DENV IgM or IgG antibodies in the patient's serum. It is early and quick identification and treatment of dengue has the potential to lower the risk of severe dengue disease-related morbidity and mortality, as well as the danger of broader outbreaks. The usual approach for detecting NS1 antigens and differentiating between the four dengue virus serotypes is ELISA. When compared to other testing procedures, ELISA kits offer a higher sensitivity. When laboratories with experienced personnel and equipment are available, ELISAs have become the favored diagnostic method because to their great sensitivity and efficiency. 

The market is growing due to technological advancements in this category, such as robust test kits given by numerous leading competitors in the market. For instance, in 2019, Abbott's PANBIO DENGUE IGG INDIRECT ELISA detected IgG antibodies to dengue antigen serotypes of 1, 2, 3, and 4 in serum as an assistance to clinical laboratory diagnosis of individuals with clinical symptoms and prior exposure consistent with dengue fever. DENV Detect NS1 ELISA Kit, which is likewise utilized for the early detection of dengue virus (DENV) NS1 antigen in human serum, is another test kit produced by In Bios International Inc. Thus, as a result of above stated factors, the market is likely to rise steadily over the forecast period (2021-2027).

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered
• Regions Covered- Globally

Competitive Landscape- including Corgenix Medical Corp, QuantuMDx Group Ltd., Quidel Corp, Sansure Biotech Inc., Whidiag SAS, Pictor Ltd. and others. 

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Dengue Diagnostics & Treatment Market Report Segment

By Testing Type

• ELISA-Based Test

• RT-PCR Based Test

• Dengue IgG/IgM Rapid Test

• Others (Serologic and Tissue Test)

By Treatment

• Medication

• Supportive Care

• Vaccination

By End Users

• Hospitals & Clinics

• Diagnostic center

Global Dengue Diagnostics & Treatment Market Report Segment by Region